Printer Friendly

AGOURON NAMES VICE PRESIDENT AND GENERAL COUNSEL

 AGOURON NAMES VICE PRESIDENT AND GENERAL COUNSEL
 SAN DIEGO, Calif., Dec. 10 /PRNewswire/ -- Agouron


Pharmaceuticals Inc. (NASDAQ-NMS: AGPH) today announced the appointment of Gary E. Friedman to the position of vice president and general counsel. Prior to accepting this position at Agouron, Friedman was a principal in the San Diego law firm of Friedman, Jay and Cramer which has served as counsel to Agouron since its inception. Friedman was a co-founder of Agouron Pharmaceuticals in 1984 and has served as a director of the company since its inception. Friedman received a J.D. and an M.B.A. from the University of California, Berkeley, and an L.L.M. degree in taxation from the University of San Diego.
 "Gary Friedman is a businessman-attorney of extraordinary capability and is a longtime Agouron advocate," said Peter Johnson, Agouron's president and chief executive officer. "We are delighted that in his new role, he will be able to concentrate full-time on helping Agouron to achieve its very ambitious commercial goals."
 Agouron Pharmaceuticals Inc. is a pioneer and leader in a new technology for the rational design of novel synthetic drugs based upon the molecular structures of proteins which play key roles in human disease. Agouron is currently applying this technology to the design and development of drugs for treatment of cancer, AIDS and other serious diseases.
 -0- 12/10/91 R
 /CONTACT: Peter Johnson, president and CEO, or Donna Nichols, manager of corporate communications of Agouron Pharmaceuticals, 619-622-3000/
 (AGPH) CO: Agouron Pharmaceuticals Inc. ST: California IN: MTC SU: PER


KD -- SD002 -- 1060 12/10/91 13:45 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 10, 1991
Words:264
Previous Article:WRITER/PRODUCER GLENN GORDON CARON SIGNS PARAMOUNT DEAL
Next Article:FDIC TO HOLD LARGEST COMMERCIAL REAL ESTATE AUCTION EVER, DEC. 12
Topics:


Related Articles
AGOURON NAMES VICE PRESIDENT AND GENERAL COUNSEL
AGOURON PHARMACEUTICALS NAMES FORMER PRESIDENT OF MERCK INTERNATIONAL TO BOARD
AGOURON PHARMACEUTICALS NAMES FORMER EXECUTIVE VICE PRESIDENT OF MARION LABORATORIES TO BOARD
AGOURON PHARMACEUTICALS NAMES ONCOLOGY ADVISORY BOARD
AGOURON PHARMACEUTICALS REPORTS FISCAL 1995 FINANCIAL RESULTS
Agouron Pharmaceuticals Reports Fiscal 1996 Financial Results
Agouron Completes Management Changes
Agouron Completes Management Changes.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters